Figure 3
Figure 3. mLCs and mDCs express functional NOD1 and NOD2. Expression of NOD1 and NOD2, and TLR3 and TLR9, which were used as controls, in mLCs and mDCs was assessed using real-time quantitative RT-PCR analysis (qPCR; A, mLCs; E, mDCs). mLCs and mDCs were stimulated by PGN (5 μg/mL), iE-DAP (for NOD1, 100 μg/mL), and MDP (for NOD2, 10 μg/mL) for 24 hours. mLCs (B-D) or mDCs (F-H) were stimulated via NOD receptors before (C,G) and after (D,H) HIV exposure. The expression of CD86 (B,F) and percentage of positive cells for HIV p24 (C,D,G,H) was assessed in langerin+ CD11c+ mLCs or CD11c+ mDCs (MFI, mean fluorescence intensity). Results are shown as means plus or minus SD (*P < .05). All data shown represent at least 2 separate experiments.

mLCs and mDCs express functional NOD1 and NOD2. Expression of NOD1 and NOD2, and TLR3 and TLR9, which were used as controls, in mLCs and mDCs was assessed using real-time quantitative RT-PCR analysis (qPCR; A, mLCs; E, mDCs). mLCs and mDCs were stimulated by PGN (5 μg/mL), iE-DAP (for NOD1, 100 μg/mL), and MDP (for NOD2, 10 μg/mL) for 24 hours. mLCs (B-D) or mDCs (F-H) were stimulated via NOD receptors before (C,G) and after (D,H) HIV exposure. The expression of CD86 (B,F) and percentage of positive cells for HIV p24 (C,D,G,H) was assessed in langerin+ CD11c+ mLCs or CD11c+ mDCs (MFI, mean fluorescence intensity). Results are shown as means plus or minus SD (*P < .05). All data shown represent at least 2 separate experiments.

Close Modal

or Create an Account

Close Modal
Close Modal